E.U. Gives Up On Single Biotech Patent System

Law360, New York (July 18, 2005, 12:00 AM EDT) -- Still stinging from its defeat in the fight for a single European patent system for software, the European Commission now appears to have given up on harmonizing patents for biotech drug innovations as well.

On Monday, the European Union’s executive body said it would allow countries to adopt different standards instead of insisting on a single European standard for patenting biotech drug innovations.

The Commission conceded that it was unlikely to reach an agreement on a single Europe-wide standard due in part to deep disagreements over...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.